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NOTES AND COMMENTS 
Letters To the Editor 
More About 
Nurse Clinicians 
Comments on 
Australia Antigen 
To the editor: 
Our article (Vol. 18, No. 3, FaU, 
1970) describing the Health Nurse 
Clinician was not intended to offer a 
solution to the problem of rising health 
care costs. The increasing use of para-
medical personnel certainly has an 
impact on cost, and nurses have led 
the way in delegating duties to others 
with less professional training. 
In Vol. 19, No. 1, Letter to the 
Editor, Mrs. Zonca points to the law 
of supply and demand as fundamental 
to rising costs. The extension of the 
physician's capability in patient care, 
in a collegial relationship with the 
Health Nurse Clinician, strongly sug-
gests a possibility of lowering costs. 
I do not agree that "No matter what 
we do, hospital cost will continue to 
increase." The fact is what we do is 
the only thing that can influence the 
cost. 
C. E. Rupe, M.D. 
To the editor: 
In reference to a recent article by 
Hayashi and LoGrippo (Vol. 19, No. 1, 
1971), the authors found Australia an-
tigen (Au) in 34% of institutionalized 
patients during a hepatitis epidemic 
which on all clinical grounds appeared 
to be "infectious" hepatitis. They con-
cluded: (1) that Au is associated with 
infectious as well as serum hepatitis 
and (2) that the test for Au was rela-
tively insensitive since it was negative 
in 66% of the hepatitis cases. 
There would appear to be a third 
and more reasonable interpretation of 
these data, namely: (a) that, as in all 
other large institutions, there was a 
high frequency of endemic anicteric 
hepatitis much of which was Au posi-
tive (The frequency of Au in Down's 
and non-Down's patients cited is 
wholly consistent with that found in 
other institutions where no such in-
fectious hepatitis outbreak has oc-
curred); (b) that the hepatitis outbreak 
was indeed Au negative infectious hep-
atitis and that the authors merely 
measured pre-existing Au antigen 
levels. 
The data are now fairly convincing 
that Au is associated with only one 
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form of the hepatitis virus. This is 
based primarily on the distinctions 
between MS-1 and MS-2 viruses iso-
lated at the Willowbrook State School 
and on the repeated failure to demon-
strate the appearance of Au in relation 
to any point source hepatitis epidemic. 
One can not contradict this accumu-
lated evidence with data derived from 
institutions for the mentally retarded 
where the incidence of Au has con-
sistently been shown to be high and 
particularly from an institution where 
no pre-epidemic samples were avail-
able for Au testing. Furthermore the 
authors present no control data on the 
incidence of Au, CRP, IgM and SGPT 
in their institutionalized patients who 
did not have clinical hepatitis. These 
data are crucial if one is to attempt to 
causally relate the presence of Au with 
the epidemic described. 
In summary, without pre-epidemic 
sera for Au determination and without 
testing "non-hepatitis" controls, the 
authors are unjustified in drawing any 
conclusions regarding the relationship 
of Au to the hepatitis epidemic re-
ported. 
Harvey J. Alter, M.D., 
Senior Investigator 
Paul V. Holland, M.D., 
Assistant Chief 
Blood Bank Department-Clinical 
Center, National Institutes of 
Health, Bethesda, Md. 
Authors' Reply 
To the editor: 
We accept Drs. Alter and Holland's 
third interpretation of our data (par. 
2b of their letter). Their elaboration of 
our discussion is welcomed because it 
must not have been clear in our inter-
pretation where we stated, ". . . we 
questioned whether our outbreak was 
I H or SH in nature. If I H and SH 
varieties were both present among pa-
tients, it would be difficult to explain 
in a relatively new institution the mixed 
hepatitis varieties present with abrupt 
onset and sudden termination in four 
to six weeks " (par. 1, page 32 of our 
pubhcation). 
Although we do not have data on 
the incidence of Au for 1962 among 
the institutional personnel, nor of the 
children before they developed hepa-
titis, the fact remains that testing for 
Au in clinically i l l patients does not 
differentiate SH from IH. In addition, 
Au-antigen positive patients do not 
convincingly develop Au-antibodies 
following convalescence. More sensi-
tive radioactive methods are being in-
vestigated for this purpose. However, 
until a more sensitive serologic method 
for demonstrating serum conversion 
from negative to positive antibody re-
sponse to Au from active infection, and 
not from parental administration oj 
homologous blood products, the asso-
ciation of Au to hepatitis virus protein 
warrants clarification from a virologic 
and immunologic standpoint. 
Drs. Alter and Holland state that 
we have no crucial control study on 
the incidence of Au, CRP, IgM and 
SGPT values. Normal serum levels for 
these factors are given under "Ma-
terials and Methods" in our publica-
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tion, with suitable references to our 
previous publications. We are not 
claiming that the presence of Au in 
34% of the I H patients in institu-
tionalized children and 23% (57 of 
244 patients) admitted to our hospital 
with active virus hepatitis should be 
considered a "causal relation to the 
presence" (as they put it) of Au in our 
studies. We suggested that "These tests 
appear to reflect the host's responses 
to nonspecific inflammatory condi-
tions " (par. 1, page 31). 
Since there is no serologic test for 
IH, as there is for Au which is hypo-
thetically assumed to be associated 
with SH, how can one differentiate I H 
from SH in acute hepatitis cases by 
testing for Au only? This is particularly 
so if we assume, as they suggest, that 
Au in our study is present as pre-
existing Au antigen levels in the pres-
ence of clinically active IH. Clinicians 
should not conclude that an active 
case of virus hepatitis is SH simply 
because the serum is Au-positive. This 
is an ever-present situation in clinical 
hepatitis and the purpose for our con-
clusion. We stand firm on our con-
clusion that more virologic and im-
munologic evidence is necessary before 
this moot question can be resolved. 
G. A. LoGrippo, M.D. 
H. Hayashi, Ph.D. 
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